Affordable Access

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

Authors
Type
Published Article
Journal
Lung Cancer
0169-5002
Publisher
Elsevier
Publication Date
Volume
42
Issue
3
Pages
345–354
Identifiers
PMID: 14644523
Source
Medline

Abstract

The combination carboplatin-gemcitabine at these doses is feasible in elderly patients with advanced non-small cell lung cancer. Tolerability and toxicity are acceptable. Response rate and survival stand in the range of the most active regimens. Comorbidity and PS showed prognostic independence.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments